There is no one-week insulin on the market, and the one-week drugs on the market are not insulin but glucagon-like peptide-1 (GLP-1) agonists, and the common drugs are exenatide microspheres, dulaglutide, simethicone, etc. The price is about 500 yuan. The price of GLP-1 agonists ranges from about 500 yuan, depending on the type of drug and different regions, the price varies, it is recommended that the specific price of the local hospitals and pharmacies shall prevail. GLP-1 receptor agonist is a kind of injectable hypoglycemic drugs, mainly by stimulating the pancreatic islet B cells to secrete insulin, and inhibit the appetite center, delay gastric emptying to increase the sense of satiety, in order to achieve the purpose of lowering sugar. It is mainly suitable for patients with type 2 diabetes who have poor glycemic control with oral hypoglycemic agents. However, GLP-1 receptor agonists may have adverse reactions such as nausea, vomiting, and abdominal pain. In addition, the drug should be used with caution in patients with severe hepatic or renal insufficiency, peptic ulcers, and gastrointestinal bleeding. GLP-1 receptor agonists need to be used under the guidance of a doctor, follow the doctor’s instructions, reasonable use of medication, the specific price of the drug to the local hospital and pharmacy shall prevail.